Arrowhead Pharmaceuticals Inc. (ARWR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arrowhead Pharmaceuticals...

    NASDAQ: ARWR · Real-Time Price · USD
    32.80
    1.14 (3.60%)
    At close: Sep 26, 2025, 3:59 PM
    33.00
    0.61%
    After-hours: Sep 26, 2025, 07:04 PM EDT

    Arrowhead Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Revenue
    		 3.55M 240.74M 243.23M 138.29M
    Cost of Revenue
    		 18.59M 12.49M 10.42M n/a
    Gross Profit
    		 3.55M 240.74M 243.23M 138.29M
    Operating Income
    		 -601.08M -205M -178.51M -149.04M
    Interest Income
    		 22.72M 15.3M 5.03M 6.12M
    Pretax Income
    		 -612.46M -206.49M -172.71M -140.85M
    Net Income
    		 -599.49M -205.28M -176.06M -140.85M
    Selling & General & Admin
    		 96.82M 90.93M 124.43M 80.98M
    Research & Development
    		 505.87M 353.19M 297.31M 206.34M
    Other Expenses
    		 1.94M 1.62M n/a n/a
    Operating Expenses
    		 604.63M 445.74M 421.74M 287.32M
    Interest Expense
    		 32.35M 18.33M n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 604.63M 445.74M 421.74M 287.32M
    Income Tax Expense
    		 -2.77M 2.78M 3.79M 2K
    Shares Outstanding (Basic)
    		 119.78M 107.31M 105.43M 103.75M
    Shares Outstanding (Diluted)
    		 119.78M 106.75M 105.43M 103.75M
    EPS (Basic)
    		 -5 -1.91 -1.67 -1.36
    EPS (Diluted)
    		 -5 -1.92 -1.67 -1.36
    EBITDA
    		 -561.51M -175.67M -162.29M -132.58M
    EBIT
    		 -580.11M -188.16M -172.71M -140.85M
    Depreciation & Amortization
    		 18.59M 12.49M 10.42M 8.27M

    Add to Watchlist